Yahoo Web Search

Search results

    • FDA Gives Nod to RSV Vaccine for People in Their 50s

      US News & World Report· 6 hours ago

      Drugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher risk from RSV disease